Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 400 News Items found Medical Oncologist Bob Li Featured in the Presidential Symposium at the 2020 World Conference on Lung Cancer Friday, January 29, 2021 Dr. Bob Li will present registrational phase II data from the first-ever trial of a drug that blocks cancer gene KRAS. How ROS1-Targeted Therapy Is Helping People With Advanced Lung Cancer Live Better, Longer Wednesday, August 12, 2026 Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies. In the Lab Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive Thursday, February 27, 2014 Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there. Feature For Some People with Cancer, a Simple Blood Test Can Be a Lifesaver Wednesday, March 20, 2019 He was given a wrong diagnosis. A blood test changed his life. In the Lab Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs Thursday, June 7, 2018 Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness. In the Lab Researchers Uncover New Findings about KRAS, an Important Protein in Cancer Friday, October 8, 2021 Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth. In the Clinic New MSK Initiative Focuses on the Early Detection and Prevention of Cancer Thursday, February 22, 2018 Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection. Snapshot T Cell Attack: Taking Down Cancer with Immunotherapy Tuesday, October 11, 2016 MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest. MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025 Monday, December 15, 2025 Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers. Feature How Four Decades of Research Led to an Important Advance in Lung Cancer Monday, May 24, 2021 Read how a clinical trial is changing the outlook for some people with lung cancer. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment